Hesperidin, a natural citrus flavanone, alleviates hyperglycaemic state and attenuates embryopathies in pregnant diabetic mice

Journal of Medicinal Plants Research

Volumn 3, Issue 11, 2009, Pages 862-869

  Toumi, Mohamed L ^a   Merzoug, Sameha ^a   Boutefnouchet, Abdellatif ^b   Tahraoui, Abdelkrim ^a   Ouali, Kheireddine ^a   Guellati, Mohamed A ^a  

^a BADJI MOKHTAR UNIVERSITY   (Algeria)

^b Department of Biophysics and Pharmaceutical Sciences   (Algeria)

Author keywords

Citrus fruits; Diabetic embryopathy; Hesperidin; Mice

Indexed keywords

ANTIOXIDANT; FLAVANONE DERIVATIVE; HESPERIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CITRUS FRUIT; CONTROLLED STUDY; DRUG POTENCY; EMBRYOPATHY; FEMALE; FETUS; FETUS MALFORMATION; FETUS RESORPTION; FETUS WEIGHT; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MATERNAL DIABETES MELLITUS; MOUSE; MOUSE STRAIN; NONHUMAN; PARAMETER; PROPHYLAXIS; SKELETON MALFORMATION; STREPTOZOCIN DIABETES; SUPPLEMENTATION; TERATOGENICITY;

CITRUS; MUS;

EID: 73649131274     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Adlercreutz H, Yamada T, Wähälä K, Watanabe S (1999). Maternal and neonatal phytoestrogens in Japanese women during birth. Am. J. Obstet. Gynecol. 180: 737-743.
2. Arredondo MF, Blasina F, Echeverry C, Morquio A, Ferreira M, Abin-Carriquiry JA, Lafon L, Dajas F (2004). Cytoprotection by Achyrocline satureioides (Lam) D.C. and some of its main flavonoids against oxidative stress. J. Ethnopharmacol. 91: 13-20.
3. Aslan M, Orhan DD, Orhan N, Sezik E, Yesilada E (2007). In vivo antidiabetic and antioxidant potential of Helichrysum plicatum ssp. plicatum capitulums in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 109: 54-59.
4. Barham D, Trinder P (1972). An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 97(151): 142-145.
5. Cederberg J, Basu S, Eriksson UJ (2001). Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia 44: 766-774.
6. Chiba H, Uehara M, Wu J, Wang X, Masuyama R, Suzuki K, Kanazawa K, Ishimi Y (2003). Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J. Nutr.133: 1892-1897.
7. Coskun O, Kanter M, Korkmaz A, Oter S (2005). Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol. Res. 51: 117-123.
8. Damasceno DC, Volpato GT, Calderon IdeMP, Rudge MVC (2002). Oxidative stress and diabetes in pregnant rats. Anim. Reprod. Sci. 72: 235-244.
9. Dufall KG, Ngadjui BT, Simeon NF, Abegaz BM, Croft KD (2003). Antioxidant activity of prenylated flavonoids from the West African medicinal plant Dorstenia mannii. J. Ethnopharmacol. 87: 67-72.
10. Erlund I (2004). Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutr. Res. 24:851-874.
11. Estany S, Palacio JR, Barnadas R, Sabes M, Iborra A, Martinez P (2007). Antioxidant activity of N-acetylcysteine, flavonoids and α-tocopherol on endometrial cells in culture. J. Reprod. Immunol. 75: 1-10.
12. Fröde TS, Medeiros YS (2008). Animal models to test drugs with potential antidiabetic activity. J. Ethnopharmacol. 115: 173-183.
13. Gao Q, Gao Y-M (2007). Hyperglycemic condition disturbs the proliferation and cell death of neural progenitors in mouse embryonic spinal cord. Int. J. Dev. Neurosci. 25: 349-357.
14. Garg A, Garg S, Zaneveld LJ, Singla AK (2001). Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother. Res. 15: 655-669.
15. Ghedira K (2005). Les flavonoïdes: structure, proprié tés biologiques, rôle prophylactique et emplois en thérapeutique. Phytothérapie 4: 162-169.
16. Ghosh S, Pulinilkunnil T, Yuen G, Kewalramani G, An D, Qi D, Abrahani A, Rodrigues B (2005). Cardiomyocyte apoptosis induced by shortterm diabetes requires mitochondrial GSH depletion. Am. J. Physiol.: Heart Circ. Physiol. 289: H768-H776.
17. Grissa O, Atégbo J-M, Yessoufou A, Tabka Z, Miled A, Jerbi M, Dramane KL, Moutairou K, Prost J, Hichami A, Akhtar Khan N (2007). Antioxidant status and circulating lipids are altered in human gestational diabetes and macrosomia. Transl. Res. 150:164-171.
18. Grohmann K, Manthey JA, Cameron RG (2000). Acid-catalyzed hydrolysis of hesperidin at elevated temperatures. Carbohydr. Res. 328: 141-146.
19. Harvey AJ, Kind KL, Thompson JG (2002). Redox regulation of early embryo development. Reprod. 123: 479-486.
20. Havsteen BH (2002). The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 96: 67-202.
21. Hendrickson R, Kesterson JW (1964). Hesperidin in Florida Oranges. In: Tech. Bull. No. 684. University of Florida: Gainesville, FL. p. 42.
22. Jones HN, Powell TL, Jansson T (2007). Regulation of placental nutrient transport. Placenta 28: 763-774.
23. Jung UJ, Lee M-K, Jeong K-S, Choi MS (2004). The Hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J. Nutr. 134: 2499-2503.
24. Jung UJ, Lee M-K, Park YB, Kang MA et Choi MS (2006). Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int. J. Biochem. Cell. Biol. 38: 1134-1145.
25. Karunanayake EH, Hearse DJ, Mellows G (1974). The synthesis of [14C] streptozotocin and its distribution and excretion in the rat. Biochem. J. 142: 673-683.
26. Kim HK, Jeong T-S, Lee M-K, Park YB, Choi MS (2003). Lipid-lowering efficacy of hesperetin metabolites in high-cholesterol fed rats. Clin. Chim. Acta. 327:129-137.
27. Kucera J (1971). Rate and type of congenital anomalies among offspring of diabetic women. J. Reprod. Med. 7:61-70.
28. Lean MEJ, Noroozi M, Kelly I, Burns J, Talwar D, Sattar N, Crozier A (1999). Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes 48:176-181.
29. R, Thorens B, Loeken MR (2007). Expression of the gene encoding the high-km glucose transporter 2 by the early post-implantation mouse embryo is essential for neural tube defects associated with diabetic embryopahy. Diabetologia 50: 682-689.
30. Loscalzo LM, Wasowski C, Paladini AC, Marder M (2008). Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines. Eur. J. Pharmacol. 580: 306-313.
31. Machado AF, Zimmerman EF, Hovland Jr. DN, Weiss R, Collins MD (2001). Diabetic embryopathy in C57BL/6J mice. Diabetes 50: 1193-1199.
32. Manthey JA, Grohmann K (1996). Concentrations of hesperidin and other orange peel flavonoids in citrus processing by-products. J. Agric. Food Chem. 44(3): 811-814.
33. Nielsen I L F, Chee W SS, Poulsen L, Offord-Cavin E, Rasmussen S E, Frederiksen H, Enslen M, Barron D, Horcajada M-N, Williamson G (2006). Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: A randomized, double-blind, crossover trial. J. Nutr. 136: 404-408.
34. Okine LKN, Nyarkob AK, Osei-Kwabenaa N, Oppongc IV, Barnesa F, Ofosuheneb M (2005). The antidiabetic activity of the herbal preparation ADD-199 in mice: a comparative study with two oral hypoglycaemic drugs. J. Ethnopharmacol. 97: 31-38.
35. Okutan H, Ozcelikb N, Yilmazb HR, Uzb E (2005). Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin. Biochem. 38: 191-196.
36. Ouali K, Trea F, Toumi L, Bairi A, Maurel D, Guellati MA (2007). L'hespéridine, un antioxydant flavonoïde qui diminue le stress oxydatif et prévient les malformations foetales au cours du diabète gestationnel expérimental. Phytothérapie 5: 204-209.
37. Pani L, Horal M, Loeken MR (2002). Polymorphic susceptibility to the molecular causes of neural tube defects during diabetic embryopathy. Diabetes 51: 2871-2874.
38. Pasten C, Olave NC, Zhou L, Tabengwa EM, Wolkowicz PE, Grenett HE (2007). Polyphenols downregulate PAI-1 gene expression in cultured human coronary artery endothelial cells: Molecular contributor to cardiovascular protection. Thromb. Res. 121: 59-65.
39. Peuchant E, Brun J-L, Rigalleau V, Dubourg L, Thomas M-J, Daniel JY, Leng J-J, Gin H (2004). Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clin. Biochem. 37: 293-298.
40. Pinto RM, Fernandes ES, Reis JEP, Peters VM, Guerra MdeO (2007). Intra-uterine growth retardation after prenatal administration of Ginkgo biloba to rats. Reprod. Toxicol. 23: 480-485.
41. Reece EA, Ma D-X, Zhao Z, Wu KY, Dhanasekaran D (2005). Aberrant patterns of cellular communication in diabetes-induced embryopathy in rats: II, Apoptotic pathways. Am. J. Obstet. Gynecol. 192: 967-972.
42. Reece EA, Wu KY, Zhao Z, Dhanasekaran D (2006). Dietary vitamin and lipid therapy rescues aberrant signalling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats. Am. J. Obst. Gynecol. 194: 580-585.
43. Roberts CT, Owens JA, Sferruzzi-Perri AN (2008). Distinct actions of insulin-like growth factors (IGFs) on placental development and fetal growth: Lessons from mice and Guinea pigs. Placenta 22(Suppl. A): S42-S47.
44. Sabu MC, Smitha K, Ramadasan K (2002). Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J. Ethnopharmacol. 83: 109-116.
45. Sakamaki H, Akazawa S, Ishibashi M, Izumino K, Takino H, Yamasaki H, Yamaguchi Y, Goto S, Urata Y, Kondo T, Nagataki S (1999). Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes 48: 1138-1144.
46. Scalbert A, Morand C, Manach C, Rémésy C (2002). Absorption and metabolism of polyphenols in the gut and impact on health. Biomed. Pharmacother. 56: 276-282.
47. Schröder-Van Der Elst JP, Van Der Heide D, Rokos H, Morreale De Escobar G, Köhrle J (1998). Synthetic flavonoids cross the placenta in the rat and are found in fetal brain. Am. J. Physiol. Endocrinol. Metab. 274: 253-256.
48. Schwartz R, Teramo KA (2000). Effects of diabetic pregnancy on the fetus and newborn. Semin. Perinatol. 24(2): 120-135.
49. Sivan E, Lee YC, Wu YK, Reece EA (1997). Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats. Teratol. 56: 343-349.
50. Staples RE, Schnell VL (1964). Refinements in rapid clearing technic in the KOH-alizarin red S method for fetal bone. Stain Technol. 39: 61-63.
51. Stoclet J-C, Chataigneau T, Ndiaye M, Oak M-H, El Bedoui J, Chataigneau M, Schini-Kerth VB (2004). Vascular protection by dietary polyphenols. Eur. J. Pharmacol. 500: 299-313.
52. Sun F, Kawasaki E, Akazawa S, Hishikawa Y, Sugahara K, Kamihira S, Koji T, Eguchi K (2005). Apoptosis and its pathway in early post-implantation embryos of diabetic rats. Diab. Res. Clin. Pract. 67: 110-118.
53. Tapiero H, Tew KD, Nguyen BG, Mathé G (2002). Polyphenols: do they play a role in the prevention of human pathologies?. Biomed. Pharmacother. 56: 200-207.
54. Todaka E, Sakurai K, Fukata H, Miyagawa H, Uzuki M, Omori M, Osada H, Ikezuki Y, Tsutsumi O, Iguchi T, Mori C (2005). Fetal exposure to phytoestrogens-The difference in phytoestrogen status between mother and fetus. Environ. Res. 99: 195-203.
55. Torchinsky A, Brokhman I, Shepshelovich J, Orenstein H, Savion S, Zaslavsky Z, Koifman M, Dierenfeld H, Fein A, Toder V (2003). Increased TNF-α expression in cultured mouse embryos exposed to teratogenic concentrations of glucose. Reprod. 125: 527-534.
56. Wise LD, Beck SL, Beltrame D, Beyer BK, Chahoud I, Clark RL, Clark L (1997). Terminology of developmental abnormalities in common laboratory mammals (version 1). Teratol. 55: 249-292.
57. Yang P, Zhao Z, Reece A (2008). Activation of oxidative stress signalling that is implicated in apoptosis with a mouse model of diabetic embryopathy. Am. J. Obstet. Gynecol. 198: 130e1-130e7.
58. Zabihi S, Eriksson UJ, Wentzel P (2007). Folic acid supplementation affects ROS scavenging enzymes, enhances Vegf-A, and diminishes apoptotic state in yolk sacs of embryos of diabetic rats. Reprod. Toxicol. 23: 486-498.
59. Zang M, Xu S, Maitland-Toolan KA, Zuccollo A, Hou X, Jiang B, Wierzbicki M, Verbeuren TJ, Cohen RA (2006). Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55: 2180-2191.